OTLK vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 05, 2026

OTLK

55.6
AI Score
VS
OTLK Wins

CBIO

54.5
AI Score

Investment Advisor Scores

OTLK

56score
Recommendation
HOLD

CBIO

55score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric OTLK CBIO Winner
Revenue 1.51M 1.04M OTLK
Net Income -49.13M -23.28M CBIO
Net Margin -3263.9% -2240.9% CBIO
Operating Income -49.75M -24.73M CBIO
ROE 132.1% -12.7% OTLK
ROA -219.4% -11.7% CBIO
Total Assets 22.39M 199.13M CBIO
Cash 8.90M 189.16M CBIO
Current Ratio 0.67 13.78 CBIO

Relative Price Performance (Last 90 Days)

OTLK 1M: -36.7% · 3M: +242.2% CBIO 1M: -8.9% · 3M: -13.8%

Current Technical Phase

OTLK

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 35.9 · Price: $0.90

CBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.8%), weak momentum, RSI 45

RSI (14): 45.0 · Price: $15.45

Fundamentals Snapshot

Metric OTLK CBIO
Market Cap
Forward P/E -5.7 -5.7
Trailing P/E
Revenue (TTM)
Revenue Growth 6.6% 0.0%
Gross Margin -3.6% 1.0%
Operating Margin -110.1% -14.3%
EPS -1.14 -0.14
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, OTLK is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.